If you think you may have symptoms of Coronavirus >, follow the national guidance and self-isolate for 10 days. Please see our information for visitors > before you plan on visiting one of our hospitals. If you, or a member of your family has tested positive for Coronavirus, please find resources to aid your/their recovery on our supporting your recovery from Coronavirus > page.
From Monday 16 March 2020, recruitment of patients to all studies, other than those studies relating to COVID-19, will cease. This is to allow our clinical colleagues to focus their care where it is most needed. We are reviewing the trials we have open and are in contact with sponsors. The safety of our patients it always our priority.
As a university Trust we believe research is key to the exceptional care provided at UHDB. Our aim is to offer every patient the opportunity to take part in research; in developing new medicines, devices and treatments.
We host research funded by external organisations including the National Institute for Health Research (NIHR), Association of Medical Research Charities (AMRC) and the life sciences industry. Conducting research studies helps the Trust realise its vision to be a beacon of the NHS, delivering 21st century healthcare.
As well as collaborating on externally led research we support home grown studies and sponsor high quality research of clear value to the NHS. From new investigators with their first ideas to multi centre randomised controlled trials, we can work with you to design, set-up and deliver your research.
A pioneering research study which aims to make operating theatres safer places during the Covid-19 pandemic and beyond is underway at University Hospitals of Derby and Burton NHS Foundation Trust (UHD...
A Renal Consultant and his colleagues have published the first piece of research in the UK and only the second in Europe about how Covid-19 patients who also develop Acute Kidney Injury (AKI) are adve...
UHDB is taking part in a national trial aiming to find out whether healthcare workers who have evidence of prior COVID-19, detected by antibody assays (positive antibody tests), compared to those who ...
We are contractually obliged to report on the performance of every clinical trial taking place in the Trust by publishing on a quarterly basis: the time from when we have been selected as a research site to the first recruited patient; and the recruitment to time and target for commercial contract clinical trials.
In this section, you will find the Lay Study Summary of studies sponsored by UHDB